Drug Shortage Report for TEVA-ATOVAQUONE PROGUANIL
| Report ID | 243583 |
| Drug Identification Number | 02380927 |
| Brand name | TEVA-ATOVAQUONE PROGUANIL |
| Common or Proper name | ATOVAQUONE/PROGUANIL 250/100MG |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PROGUANIL HYDROCHLORIDE ATOVAQUONE |
| Strength(s) | 100MG 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | PP12 |
| ATC code | P01BB |
| ATC description | ANTIMALARIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-11-20 |
| Estimated end date | 2025-01-31 |
| Actual end date | 2025-02-05 |
| Shortage status | Resolved |
| Updated date | 2025-02-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2025-02-06 | French | Compare |
| v11 | 2025-02-06 | English | Compare |
| v10 | 2025-01-09 | French | Compare |
| v9 | 2025-01-09 | English | Compare |
| v8 | 2024-12-13 | French | Compare |
| v7 | 2024-12-13 | English | Compare |
| v6 | 2024-12-04 | French | Compare |
| v5 | 2024-12-04 | English | Compare |
| v4 | 2024-11-28 | French | Compare |
| v3 | 2024-11-28 | English | Compare |
| v2 | 2024-11-21 | French | Compare |
| v1 | 2024-11-21 | English | Compare |
Showing 1 to 12 of 12